Assay strategies for identification of therapeutic leads that target protein trafficking

作者: P. Michael Conn , Timothy P. Spicer , Louis Scampavia , Jo Ann Janovick

DOI: 10.1016/J.TIPS.2015.05.004

关键词:

摘要: Receptors, enzymes, and ion channels are traditional targets of therapeutic development. A common strategy is to target these proteins with agents that either activate or suppress their activity ligands substrates occupy orthosteric sites have allosteric interactions. An alternative approach involves regulation protein trafficking. In principle, this enables 'rescue' misfolded misrouted mutant restore function, 'shipwrecking' undesirable by targeting them for destruction, levels partially expressed wild type (WT) at functional action. Here, we present drug discovery strategies identify 'pharmacoperones', which small molecules serve as molecular templates cause otherwise fold route correctly.

参考文章(85)
Franck Madoux, Jo Ann Janovick, David Smithson, Sonia Fargue, Christopher J. Danpure, Louis Scampavia, Yih-Tai Chen, Timothy P. Spicer, P. Michael Conn, Development of a phenotypic high-content assay to identify pharmacoperone drugs for the treatment of primary hyperoxaluria type 1 by high-throughput screening. Assay and Drug Development Technologies. ,vol. 13, pp. 16- 24 ,(2015) , 10.1089/ADT.2014.627
M.P. Krebs, S.M. Noorwez, R. Malhotra, S. Kaushal, K.A. Smith, J.H. McDowell, Retinoids Assist the Cellular Folding of the Autosomal Dominant Retinitis Pigmentosa Opsin Mutant P23H Investigative Ophthalmology & Visual Science. ,vol. 45, pp. 3630- 3630 ,(2004)
Min Lu, Lena Staszewski, Fernando Echeverri, Hong Xu, Bryan D Moyer, Endoplasmic reticulum degradation impedes olfactory G-protein coupled receptor functional expression BMC Cell Biology. ,vol. 5, pp. 34- 34 ,(2004) , 10.1186/1471-2121-5-34
Laurence Bulteau-Pignoux, Yvette Mettey, Thierry Métayé, Iolo J. M. Doull, Luis J. V. Galietta, Michael A. Gray, M. Rachel Morris, Malcolm M. C. Pereira, Jean-Michel Vierfond, Frédéric Becq, Robert L. Dormer, Margaret A. McPherson, Ceinwen M. McNeilly, Renaud Dérand, Correction of delF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells Journal of Cell Science. ,vol. 114, pp. 4073- 4081 ,(2001)
Alfredo Ulloa-Aguirre, Jo Ann Janovick, Shaun P. Brothers, P. Michael Conn, Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease. Traffic. ,vol. 5, pp. 821- 837 ,(2004) , 10.1111/J.1600-0854.2004.00232.X
Syed M. Noorwez, Ritu Malhotra, J. Hugh McDowell, Karen A. Smith, Mark P. Krebs, Shalesh Kaushal, Retinoids Assist the Cellular Folding of the Autosomal Dominant Retinitis Pigmentosa Opsin Mutant P23H Journal of Biological Chemistry. ,vol. 279, pp. 16278- 16284 ,(2004) , 10.1074/JBC.M312101200
Jo Ann Janovick, Shaun P. Brothers, Anda Cornea, Eugene Bush, Mark T. Goulet, Wallace T. Ashton, Daryl R. Sauer, Fortuna Haviv, Jonathan Greer, P. Michael Conn, Refolding of misfolded mutant GPCR: Post-translational pharmacoperone action in vitro Molecular and Cellular Endocrinology. ,vol. 272, pp. 77- 85 ,(2007) , 10.1016/J.MCE.2007.04.012
Paul J. Muchowski, Jennifer L. Wacker, Modulation of neurodegeneration by molecular chaperones Nature Reviews Neuroscience. ,vol. 6, pp. 11- 22 ,(2005) , 10.1038/NRN1587
Carla G. Monico, Sandro Rossetti, Julie B. Olson, Dawn S. Milliner, Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele Kidney International. ,vol. 67, pp. 1704- 1709 ,(2005) , 10.1111/J.1523-1755.2005.00267.X